Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The Oelde campus is expected to expand annual tablet production capacity to up to 10 billion tablets.
September 1, 2026
By: Charlie Sternberg
Rottendorf Pharma has started building its Rottendorf Campus in Oelde, Germany, a major investment designed to expand manufacturing capacity for the global pharmaceutical industry.
The first phase includes a production facility and integrated logistics infrastructure. Rottendorf is investing more than €30 million ($34.8 million) in this initial phase, with total investments expected to exceed €100 million ($116 million) over the long term.
The new campus is scheduled to begin operations in 2028. Upon full build-out, the company expects to increase its annual production capacity from approximately five billion to up to ten billion tablets.
“With the new campus, we are creating the foundation to grow alongside our customers while providing additional capacity and advanced manufacturing technologies,” said Marco Niemann, Managing Director of Rottendorf Pharma. “This investment strengthens our ability to support future customer programs with greater flexibility, scalability, and long-term reliability.”
A key advantage for customers is the opportunity to engage early in the development of the new manufacturing environment. Because the facility is being built on a largely undeveloped greenfield site, production areas can be designed and configured to support future product requirements and process needs.
“New manufacturing capacity of this scale is rare in today’s CDMO market,” said Erich Scheibner, Managing Director of Rottendorf Pharma. “This creates a unique opportunity for customers to influence facility planning at an early stage and secure long-term growth capacity. Together, we can develop manufacturing environments that are optimally aligned with future products and market demands.”
The campus has been designed as a long-term growth platform with the potential for additional production areas, laboratory space, and supporting infrastructure. Sustainability is also a key component of the project. Plans include DGNB Gold certification, an electrification-focused energy concept, and on-site photovoltaic power generation.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !